Evidence map›Paper›PMID 32930566›Full record

ArticleACS chemical biology2020

Synthetic Fluorinated l-Fucose Analogs Inhibit Proliferation of Cancer Cells and Primary Endothelial Cells.

Yuanwei Dai, Ruth Hartke, Chao Li, Qiang Yang, Jun O Liu, Lai-Xi Wang

Abstract read
In one paragraph

Article in ACS chemical biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Synthesis and Antiproliferative Activity of FluorinatedThe Journal of organic chemistry · 2026
    Article
  2. Review
  3. Stereoselective Ferrier-Type O-Glycosylation Enabled by Difluoromethylated Glycal Donors.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. C-6-Modified 2-F-Fucose Derivatives as Inhibitors of Fucosyltransferases.Chembiochem : a European journal of chemical biology · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Fucosylation in Urological Cancers.International journal of molecular sciences · 2021
    Review
  15. Article
  16. Cellular Fucosylation Inhibitors Based on Fluorinated Fucose-1-phosphates*.Chemistry (Weinheim an der Bergstrasse, Germany) · 2021
    Article
  17. FUT8 Alpha-(1,6)-Fucosyltransferase in Cancer.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuanwei DaiDepartment of Chemistry and Biochemistry, University of Maryland, College Park, Maryland 20742, United States.
Ruth HartkeDepartment of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, United States.
Chao LiDepartment of Chemistry and Biochemistry, University of Maryland, College Park, Maryland 20742, United States.ORCID 0000-0002-8090-2017
Qiang YangDepartment of Chemistry and Biochemistry, University of Maryland, College Park, Maryland 20742, United States.
Jun O LiuDepartment of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, United States.ORCID 0000-0003-3842-9841
Lai-Xi WangDepartment of Chemistry and Biochemistry, University of Maryland, College Park, Maryland 20742, United States.ORCID 0000-0003-4293-5819

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI Rosalie Wollett · 1985 to 2026
$208.6M
Covergent Chemoenzymatic Synthesis of Glycopeptides and GlycoproteinsR01GM080374 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI WANG, LAI-XI · 2007 to 2021
$3.9M
NCI NIH HHS P30 CA006973NIGMS NIH HHS R01 GM080374
6 · The paper itself

Abstract

Fucosylation is one of the most prevalent modifications on N- and O-glycans of glycoproteins, and it plays an important role in various cellular processes and diseases. Small molecule inhibitors of fucosylation have shown promise as therapeutic agents for sickle cell disease, arthritis, and cancer. We describe here the design and synthesis of a panel of fluorinated l-fucose analogs bearing fluorine atoms at the C2 and/or C6 positions of l-fucose as metabolic fucosylation inhibitors. Preliminary study of their effects on cell proliferation revealed that the 6,6-difluoro-l-fucose (

Indexed as

Antineoplastic AgentsCarbohydrate SequenceCell Line, TumorCell ProliferationDrug DesignDrug Evaluation, PreclinicalDrug Screening Assays, AntitumorEndothelial CellsEnzyme AssaysEnzyme InhibitorsFucoseFucosyltransferasesHumansHuman Umbilical Vein Endothelial CellsMolecular StructureAntineoplastic AgentsEnzyme InhibitorsFucoseFucosyltransferasesGlycoprotein 6-alpha-L-fucosyltransferase

Identifiers

PMID32930566
PMCPMC10901565

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.